Allergan Inc (AGN) 169.35 $AGN
Auxilium Mulls Endo Bid; Street Eyes A Higher Price
at Investor's Business Daily - 2 hrs 33 mins ago
Specialty drugmaker Auxilium Pharmaceuticals (AUXL) adopted a poison-pill provision Wednesday to fend off a possible hostile bid from Endo International (ENDP), the morning after Endo announced an unsolicited $2.2 billion bid for Auxilium....
Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today
at The Street - Wed Sep 17, 7:28AM CDT
Some of the top 20 investors are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals, and are pressing Salix to consider selling itself.
Valeant, Allergan settle suit
at Investor's Business Daily - Tue Sep 16, 5:53PM CDT
Specialty drug giant Valeant Pharmaceuticals (VRX) agreed to drop its lawsuit vs. hostile-takeover target Allergan (AGN) in exchange for Allergan allowing the originally scheduled Dec. 18 special shareholder meeting that could speed a merger....
Roche Starts Trials on Lampalizumab for Geographic Atrophy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 5:10PM CDT
Roche (RHHBY) announced that it has initiated two phase III studies on ophthalmology candidate, lampalizumab.
AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 4:20PM CDT
AstraZeneca (AZN) has entered into an agreement with Eli Lilly and Company (LLY) for the development and commercialization of AZD3293.
Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 3:45PM CDT
Gild (GILD) inked deals to make generic Sovaldi available to developing nations.
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 2:50PM CDT
Avanir (AVNR) reported positive data on AVP-923.
Why It's Time for Allergan Shareholders to Take Some Profits
at The Street - Tue Sep 16, 12:09PM CDT
The current dividend does not pay enough for investors to stay.
Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote
at Investor's Business Daily - Tue Sep 16, 10:36AM CDT
Specialty-drug giant Valeant Pharmaceuticals International (VRX) agreed to drop its litigation against hostile-takeover target Allergan in exchange for Allergan allowing the originally scheduled Dec. 18 special shareholder meeting that could speed...
Allergan agrees to move forward with meeting
AP - Tue Sep 16, 6:18AM CDT
NEW YORK (AP) — Allergan and Pershing Square have agreed on at least one step toward settling a fight over the makeup of the Botox-maker's board.
Pershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of Chancery
Business Wire - Tue Sep 16, 12:39AM CDT
Pershing Square Capital Management, L.P. ("Pershing Square"
and Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) ("Valeant" announced an agreement with Allergan, Inc. (NYSE:AGN) ("Allergan" to settle pending litigation before the Delaware Court of Chancery.
Skylit Medical Announces Chairmanship of David F. Hale
PRWeb - Tue Sep 16, 12:02AM CDT
Skylit Medical announces the formation of the corporation under the Chairmanship of David F. Hale. The company is dedicated to providing personal, private, UV therapy for patients with psoriasis, eczema and vitiligo. Their devices will be used in patient homes but can connect wirelessly to a dermatologist, clinic, managed care organization or telehealth platform.
Allergan to Hold Special Meeting of Stockholders on Originally Scheduled Date of December 18 without Restriction
Business Wire - Mon Sep 15, 10:36PM CDT
--Valeant and Pershing Square Agree to Dismiss Pending Litigation in Delaware
NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 6:05PM CDT
The EMDAC of the FDA recommended the approval of NPS Pharmaceuticals' Natpara.
Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 6:00PM CDT
Alnylam (ALNY) expanded its pipeline with ALN-AGT a subcutaneously administrated RNAi therapeutic that targets AGT.
QLT Unveils Positive Retreatment Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 5:50PM CDT
QLT (QLTI) announced encouraging final data on QLT091001.
Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:35PM CDT
Novartis (NVS) presented encouraging data on Lucentis and Jetrea at the EURETINA congress in London.
Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:20PM CDT
Abbott Laboratories (ABT) announced positive one-year results from the randomized, controlled trial ABSORB II, on its drug-eluting coronary bioresorbable vascular scaffold (BVS) Absorb.
Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:30PM CDT
Eli Lilly and Company (LLY) announced that Cyramza met the primary endpoint in a phase III study (RAISE) conducted in patients suffering from metastatic colorectal cancer.
Ackman's New Fund Could Spur More Market Activism
at Investor's Business Daily - Mon Sep 15, 11:22AM CDT
Bill Ackman's Pershing Square Capital Management plans to raise $2 billion with a new fund listing on the Euronext Amsterdam stock exchange, the company said in a statement Monday. The hedge fund has already secured $1.5 billion from 30 cornerstone...
Auxilium Mulls Endo Bid; Street Eyes A Higher Price
at Investor's Business Daily - 2 hrs 33 mins ago
Specialty drugmaker Auxilium Pharmaceuticals (AUXL) adopted a poison-pill provision Wednesday to fend off a possible hostile bid from Endo International (ENDP), the morning after Endo announced an unsolicited $2.2 billion bid for Auxilium....
Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today
at The Street - Wed Sep 17, 7:28AM CDT
Some of the top 20 investors are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals, and are pressing Salix to consider selling itself.
Valeant, Allergan settle suit
at Investor's Business Daily - Tue Sep 16, 5:53PM CDT
Specialty drug giant Valeant Pharmaceuticals (VRX) agreed to drop its lawsuit vs. hostile-takeover target Allergan (AGN) in exchange for Allergan allowing the originally scheduled Dec. 18 special shareholder meeting that could speed a merger....
Roche Starts Trials on Lampalizumab for Geographic Atrophy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 5:10PM CDT
Roche (RHHBY) announced that it has initiated two phase III studies on ophthalmology candidate, lampalizumab.
AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 4:20PM CDT
AstraZeneca (AZN) has entered into an agreement with Eli Lilly and Company (LLY) for the development and commercialization of AZD3293.
Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 3:45PM CDT
Gild (GILD) inked deals to make generic Sovaldi available to developing nations.
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 2:50PM CDT
Avanir (AVNR) reported positive data on AVP-923.
Why It's Time for Allergan Shareholders to Take Some Profits
at The Street - Tue Sep 16, 12:09PM CDT
The current dividend does not pay enough for investors to stay.
Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote
at Investor's Business Daily - Tue Sep 16, 10:36AM CDT
Specialty-drug giant Valeant Pharmaceuticals International (VRX) agreed to drop its litigation against hostile-takeover target Allergan in exchange for Allergan allowing the originally scheduled Dec. 18 special shareholder meeting that could speed...
Allergan agrees to move forward with meeting
AP - Tue Sep 16, 6:18AM CDT
NEW YORK (AP) — Allergan and Pershing Square have agreed on at least one step toward settling a fight over the makeup of the Botox-maker's board.
Pershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of Chancery
Business Wire - Tue Sep 16, 12:39AM CDT
Pershing Square Capital Management, L.P. ("Pershing Square"
and Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) ("Valeant" announced an agreement with Allergan, Inc. (NYSE:AGN) ("Allergan" to settle pending litigation before the Delaware Court of Chancery. Skylit Medical Announces Chairmanship of David F. Hale
PRWeb - Tue Sep 16, 12:02AM CDT
Skylit Medical announces the formation of the corporation under the Chairmanship of David F. Hale. The company is dedicated to providing personal, private, UV therapy for patients with psoriasis, eczema and vitiligo. Their devices will be used in patient homes but can connect wirelessly to a dermatologist, clinic, managed care organization or telehealth platform.
Allergan to Hold Special Meeting of Stockholders on Originally Scheduled Date of December 18 without Restriction
Business Wire - Mon Sep 15, 10:36PM CDT
--Valeant and Pershing Square Agree to Dismiss Pending Litigation in Delaware
NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 6:05PM CDT
The EMDAC of the FDA recommended the approval of NPS Pharmaceuticals' Natpara.
Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 6:00PM CDT
Alnylam (ALNY) expanded its pipeline with ALN-AGT a subcutaneously administrated RNAi therapeutic that targets AGT.
QLT Unveils Positive Retreatment Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 5:50PM CDT
QLT (QLTI) announced encouraging final data on QLT091001.
Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:35PM CDT
Novartis (NVS) presented encouraging data on Lucentis and Jetrea at the EURETINA congress in London.
Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:20PM CDT
Abbott Laboratories (ABT) announced positive one-year results from the randomized, controlled trial ABSORB II, on its drug-eluting coronary bioresorbable vascular scaffold (BVS) Absorb.
Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:30PM CDT
Eli Lilly and Company (LLY) announced that Cyramza met the primary endpoint in a phase III study (RAISE) conducted in patients suffering from metastatic colorectal cancer.
Ackman's New Fund Could Spur More Market Activism
at Investor's Business Daily - Mon Sep 15, 11:22AM CDT
Bill Ackman's Pershing Square Capital Management plans to raise $2 billion with a new fund listing on the Euronext Amsterdam stock exchange, the company said in a statement Monday. The hedge fund has already secured $1.5 billion from 30 cornerstone...
